We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Booz Allen: FDA Should Analyze Cause of Withdrawn Submissions
Booz Allen: FDA Should Analyze Cause of Withdrawn Submissions
An audit of the FDA’s device review process recommends that the agency analyze the root cause of withdrawn submissions and create mechanisms to reduce their occurrence — good news for devicemakers fed up with inefficient reviews.